RACHELLE DOODY to Supranuclear Palsy, Progressive
This is a "connection" page, showing publications RACHELLE DOODY has written about Supranuclear Palsy, Progressive.
Connection Strength
0.246
-
Predicting disease progression in progressive supranuclear palsy in multicenter clinical trials. Parkinsonism Relat Disord. 2016 07; 28:41-48.
Score: 0.131
-
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial. Lancet Neurol. 2014 Jul; 13(7):676-85.
Score: 0.115